Adjuvant effects on protection and immune response of Japanese flounder immunized by the formalin-killed cells of Edwardsiella tarda

Adjuvant effects on protection and immune response of Japanese flounder immunized by the formalin-killed cells of Edwardsiella tarda

Accepted Manuscript Adjuvant effects on protection and immune response of Japanese flounder immunized by the formalin-killed cells of Edwardsiella tar...

462KB Sizes 0 Downloads 12 Views

Accepted Manuscript Adjuvant effects on protection and immune response of Japanese flounder immunized by the formalin-killed cells of Edwardsiella tarda Hidehiro Kondo, Seangmin Chung, Eriko Hirosawa, Ikuo Hirono PII:

S1050-4648(18)30615-6

DOI:

10.1016/j.fsi.2018.09.071

Reference:

YFSIM 5592

To appear in:

Fish and Shellfish Immunology

Received Date: 30 May 2018 Revised Date:

19 September 2018

Accepted Date: 25 September 2018

Please cite this article as: Kondo H, Chung S, Hirosawa E, Hirono I, Adjuvant effects on protection and immune response of Japanese flounder immunized by the formalin-killed cells of Edwardsiella tarda, Fish and Shellfish Immunology (2018), doi: https://doi.org/10.1016/j.fsi.2018.09.071. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT

1

Adjuvant effects on protection and immune response of Japanese

2

flounder immunized by the formalin-killed cells of Edwardsiella tarda

RI PT

3 4

Hidehiro Kondo*, Seangmin Chung*, Eriko Hirosawa, Ikuo Hirono

5

*, equally contributed.

SC

6

Laboratory of Genome Science, Graduate School of Tokyo University of Marine

8

Science and Technology, Konan 4-5-7, Minato-ku, Tokyo 108-8477, Japan

M AN U

7

9

Corresponding author: Hidehiro Kondo

11

TEL: +81-3-5463-0174. FAX: +81-3-5463-0174.

12

E-mail: [email protected]

13

Address: Laboratory of genome science, Tokyo University of Marine Science and

14

Technology, Konan 4-5-7, Minato-ku, Tokyo 108-8477, Japan

EP AC C

15

TE D

10

1

ACCEPTED MANUSCRIPT

16

Abstract We evaluated the effects of Freund’s adjuvants (FCA/FIA) on protection and

18

immune response of Japanese flounder Paralichthys olivaceus immunized by the

19

formalin-killed cell (FKC) of Edwardsiella tarda. Combination of FKC and FCA/FIA

20

did not confer protection against the challenge, while they significantly induced higher

21

antibody titers than that of FKC only. The suppression of FKC-dependent induction of

22

interferon γ (IFNγ) mRNA levels by FCA/FIA was observed by gene expression

23

profiling. Similarly, interleukin (IL)-12 p35 mRNA levels were not detected after

24

FKC+FCA or +FIA. These results suggest that the mineral oil in Freund’s adjuvants

25

might suppress the signaling pathway(s) that induce IFNγ and IL-12 gene expression.

M AN U

SC

RI PT

17

AC C

EP

TE D

26

2

ACCEPTED MANUSCRIPT

27

Introduction Edwardsiellosis causes economic losses in many cultured fish species in Japan

29

including Japanese eel Aguilla japonica (Egusa et al. 1976), Japanese flounder

30

Paralichthys olivaceus (Nakatsugawa et al. 1983) and Red sea bream Pagrus major

31

(Yasunaga et al. 1982). The causative agent, Edwardsiella tarda, is an intracellular

32

pathogen. The bacteria can survive in phagocytes and resist against bactericidal

33

activities of the host defense system (Miyazaki and Kaige 1985, Iida and Wakabayashi

34

1993, Srinivasa Rao et al. 2001).

M AN U

SC

RI PT

28

The formalin-killed cells (FKC) vaccine does not protect Japanese flounder against

36

edwardsiellosis. Mekuchi et al. (1995) reported that the mortality of the fish immunized

37

with the FKC, extracellular products or intracellular components of the bacteria was

38

similar to the mortality of unimmunized fish. The relative percent survivals (RPSs) of

39

Japanese flounder vaccinated with an attenuated strain or a natural avirulent isolate

40

were significantly high (Cheng et al. 2010, Sun et al. 2010). On the other hand,

41

vaccination with five avirulent strains provided only limited protection (Takano et al.

42

2010). For example, the RPS obtained with one of these strains was only 45 %.

43

Therefore, the effectiveness of a vaccine can strongly depend on the strain. Moreover,

44

some subunit- or DNA vaccines against bacteria provided protection against bacterial

45

challenge (Park et al. 2012).

AC C

EP

TE D

35

46

In aquaculture, vaccine adjuvants can modify the immune responses of fish. They

47

may enhance antibody responses and provide a long-lasting protection against diseases.

48

Freund's complete/incomplete adjuvants (FCA/FIA) have been extensively used in the

3

ACCEPTED MANUSCRIPT

immunological studies, in which they have been shown to stimulate both humoral and

50

cell-mediated adaptive immune responses (Tafalla et al. 2013). FCA is a moisture of a

51

mineral oil with heat-killed Mycobacteria cells, while FIA lacks the Mycobacteria cells.

52

In E. tarda infection in Japanese flounder, a recombinant protein of major antigen Et49

53

combined with FIA showed an RPS of 81 %, although the antigen by itself had an RPS

54

of only 34 % (Jiao et al. 2010). In contrast, FCA/FIA had only limited effects in other

55

fish species (Tafalla et al. 2013).

SC

RI PT

49

In order to develop an effective vaccine by using adjuvants, it is necessary to

57

understand how the adjuvants modulate fish immune responses. Here we elucidated the

58

effects of the FCA/FIA on protection and immune response of Japanese flounder

59

immunized by the E. tarda FKC. The adjuvants strongly enhanced antibody responses 2

60

weeks post infection (w.p.i.). A microarray analysis revealed that FCA/FIA suppressed

61

the upregulation of interferon-γ mRNA levels.

TE D

EP

62

M AN U

56

Materials and methods

64

Fish sampling and challenge test

65

AC C

63

Fish, average total length of 12 cm, were intraperitoneally injected with phosphate

66

buffered saline (PBS), 1 x 109 cells of FKC of E. tarda (strain NUS806), and 1 x 109

67

cells of FKC mixed with FCA (FKC+FCA) or that with FIA (FKC+FIA). The injected

68

fish were reared at 18 °C, and then spleen was sampled at 6 h and on 3 d after

69

immunization. The blood was taken from the fish at 2 w.p.i. to be assessed by ELISA.

70

Ten of the fish were intraperitoneally challenged with 1.5 x 105 cells of E. tarda at 4

4

ACCEPTED MANUSCRIPT

71

weeks after immunization and mortality was recorded.

72 Antibody titration using ELISA

RI PT

73

The antibody activities were measured by the method of Taechavasonyoo et al.

75

(2013). Briefly, the ELISA plate (Thermo) was prepared by placing 109 cells of the FKC

76

in 100 µl per well and incubated at 4 ºC overnight. The wells were washed three times

77

with T-PBS (0.05% Tween 20 in PBS), covered with 100 µl of blocking solution (3%

78

Skim milk) at room temperature for 2 h, washed three times with T-PBS, treated with

79

100 µl of primary fish antisera diluted 20-times with PBS, incubated at room

80

temperature for 1 h, washed three times with T-PBS, reacted with 1:3000 of

81

anti-Japanese flounder IgM rabbit antiserum (Taechavasonyoo et al. 2013), washed

82

three times with T-PBS, incubated with 1:1000 of anti-rabbit IgG conjugated with

83

alkaline phosphatase (Sigma) to detect the rabbit IgG, washed five times, incubated

84

with phosphatase substrate at room temperature for 30 min, and mixed with 50 µl of 3M

85

NaOH to stop the reaction. The absorbance at 405 nm was measured with Multiskan FC

86

Microplate Photometer (Thermo Scientific, Japan).

88

M AN U

TE D

EP

AC C

87

SC

74

Gene expression profiling by microarray

89

Gene expression was profiled by the method of Kaneshige et al. (2016). Total RNA

90

was extracted from spleen samples (n=3) using RNAiso Plus (Takara Bio, Japan) and

91

purified with an RNeasy® Mini Kit (Qiagen, USA). RNA quality was evaluated using a

92

2200 TapeStation (Agilent, USA). The microarray was analyzed using three samples in

5

ACCEPTED MANUSCRIPT

each group, and each sample was selected based on RNA quality. cDNA was

94

synthesized from 200 ng of RNA and labeled with cyanine 3-CTP using a one-color

95

microarray-based gene expression analysis following instructions of the manufacturer

96

(Agilent, USA). The labeled cDNA was subsequently hybridized at 65 °C for 17 h.

RI PT

93

Microarrays were scanned with an Agilent G2565CA Microarray Scanner, and the

98

images obtained from scanning were analyzed with Feature Extraction Software

99

v9.5.3.1 (Agilent, USA). The data were normalized and analyzed using limma (Ritchie

100

et al. 2015). The fold-change differences were calculated against the average of those

101

before treatments. Genes with a fold change of at least 8.0 and p value less than 1e-5

102

were considered to be differentially expressed.

M AN U

SC

97

103

IFNγ and IL-12p35 genes expression profiling by qPCR

TE D

104

The primers for the IFNγ, IL-12p35 and elongation factor 1 alpha (EF-1α) genes

106

are shown in Supplemental Table. Total RNA was extracted from the spleen of each

107

sample (n=5) using RNAiso (Takara, Japan) and 2 µg of total RNA was used for cDNA

108

synthesis using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems,

109

USA) according to the manufacturer's instructions. The cDNA samples were diluted

110

5-times with distilled water. qRT-PCR was performed using 5 µl cDNA in a

111

THUNDERBIRD SYBR qPCR Mix (TOYOBO, Japan) using an ABI7300 Real-time

112

PCR system (Applied Biosystems, USA). The expression levels of the target genes were

113

normalized to the expression level of an internal control gene (EF-1α) and the relative

114

mRNA levels were calculated by the 2-∆∆Ct method (Livak and Schmittgen, 2001), and

AC C

EP

105

6

ACCEPTED MANUSCRIPT

standardized to the average value of the PBS-injected group on the corresponding

116

sampling points. The significance of differences between values on the standard and the

117

others were evaluated by ANOVA followed by Dunnett’s post hoc test.

118 Results and Discussion

120

Effects of Freund’s adjuvants on FKC vaccine

SC

119

RI PT

115

Fish mortality was observed on day 4 after the challenge (Fig. 1A). All of the fish

122

immunized with FKC+FCA died by 7 days after the challenge and all of the fish

123

immunized with +FIA died by 6 days after the challenge. Unimmunized fish and fish

124

immunized with FKC survived longer than those immunized with FKC+FCA and +FIA.

125

Jiao et al. (2010) reported that the relative percent survival (RPS) of fish immunized

126

with an antigen with FIA was 81 %, and that the RPS of fish immunized with only the

127

antigen was 34 %. Tang et al (2010) also claimed that the antigens mixed with FIA

128

showed higher RPS than the controls. In this study, we used FKC but not certain

129

antigens, and thus the immune-response after the vaccination might be different from

130

the response of those immunized with antigens mixed with FIA.

132

TE D

EP

AC C

131

M AN U

121

Effects of Freund’s adjuvants on the antibody titer

133

Antibody levels in fish immunized with FKC, FKC+FCA or FKC+FIA were

134

significantly higher than those in the PBS group (Fig. 1B). Moreover, the FKC+FCA

135

and FKC+FIA groups showed higher antibody levels than the FKC group. Although the

136

antibody levels in the fish immunized with FKC+FCA and +FIA were higher than those

7

ACCEPTED MANUSCRIPT

in the other groups, these fish were susceptible to the bacterial challenge (see Fig. 1A).

138

The specific antibody, which opsonize the bacteria, enhance adhesion of E. tarda to

139

phagocytes, where the bacteria is able to survive and replicate (Srinivasa Rao et al.

140

2001). Therefore, the specific antibodies elicited by the FKC with the adjuvants did not

141

confer to the protection against the bacteria.

143

Gene expression profiles after the vaccination

SC

142

RI PT

137

The gene expression profiles in the spleen were compared between fish immunized

145

with FKC+FCA and fish immunized with only FKC. The microarray data were

146

deposited into the gene expression omnibus database under accession number

147

GSE111115. In the samples at 6 h after FKC immunization, the intensities of 222 spots

148

were at least 8- fold higher (p < 105) than they were before immunization, while in the

149

samples at 6 h after FKC+FCA immunization, the intensities of 213 spots were at least

150

8- fold higher. Similarly, the intensities of 214 spots were higher at 3 d after

151

immunization. The mRNA levels of some cytokines (CC chemokine, interleukin (IL)-1β

152

and IL-6) increased at 6 h in the FKC immunized group (Table 1). Almost all of the

153

spots showed similar patterns between the FKC and FKC+FCA immunization (data not

154

shown). In Japanese flounder, the genes induced by the injection of certain bacterial

155

FKC were not significantly different, while the magnitude of up- or down regulation

156

was distinct between the bacterial species (Kondo et al. 2014). Although mycobacteria

157

cell components in FCA have been thought to influence gene expression in mammals

158

(Behr et al. 2015, Ishikawa et al. 2017), they may have limited effects in fish.

AC C

EP

TE D

M AN U

144

8

ACCEPTED MANUSCRIPT

Only the intensities of the spots corresponding to interferon γ (IFNγ) were

160

significantly higher in the FKC-immunized fish, but they were not significantly

161

different in the FKC+FCA group (Table 1). It should be noted that only the IFNγ gene

162

was differently regulated between FKC and FKC+FCA groups. The IFNγ mRNA level

163

at 6 h after FKC immunization was significantly higher than it was in the other groups,

164

while the levels at on 3d were not significantly changed (Fig. 1C). The IFNγ mRNA

165

levels at 6 h also did not increase in FKC+FIA group. Therefore, regulation of the IFNγ

166

gene expression might be caused by mineral oil forming an emulsion but not by the

167

cellular components of mycobacteria.

M AN U

SC

RI PT

159

In mammals, interleukin (IL)-12 upregulates IFNγ transcription. IL-12 is an

169

inflammatory cytokine, composed of p35 and p40 subunits (Watford et al. 2003,

170

Zundler and Neurath 2015). Because the microarray did not have spots for the IL-12

171

subunits, we further investigated changes IL-12p35 subunit mRNA levels by qPCR. As

172

in the case of IFNγ, the IL-12p35 mRNA level at 6 h after FKC immunization was

173

significantly higher than the other groups (Fig. 1D). Interestingly, at 3 d, the IL-12p35

174

mRNA level was significantly lower in the FKC+FCA-immunized fish than in the

175

control. In the amberjack, FKC vaccine with recombinant IL-12 showed effective

176

against the intracellular bacterium Nocardia seriolae (Matsumoto et al. 2017). IL-12

177

and IFNγ regulate the balance between the Th1 and Th2 responses, which act against

178

intracellular bacteria and regulate antibody production, respectively (Watford et al. 2003,

179

Zundler and Neurath, 2015), and induce cell mediated immunity (Matsumoto et al.

180

2017). Therefore, the fish immunized with FKC+FCA/FIA, which showing lower IL-12

AC C

EP

TE D

168

9

ACCEPTED MANUSCRIPT

181

and IFNγ mRNA levels might show lower cell mediated immune responce. In conclusion, adding Freund's adjuvants to the vaccines resulted in higher antibody

183

titers and, and suppress the upregulation of IL-12 and IFNγ mRNA levels. Our data

184

raise the possibility that the signaling pathways involved in IL-12 and IFNγ induction

185

might be distinct from the other inflammatory pathways. Because IL-12 and IFNγ are

186

important in the Th1 response, further studies are needed to characterize the signaling

187

pathways regulating IL-12 and IFNγ expression to develop effective vaccines against

188

intracellular bacteria.

M AN U

SC

RI PT

182

189

193

25292125.

TE D

192

This research was supported in part by grants from JSPS KAKENHI Grant Number

EP

191

Acknowledgements

AC C

190

10

ACCEPTED MANUSCRIPT

194

References

195

Behr MA, Divangahi M. Freund's adjuvant, NOD2 and mycobacteria. Curr Opin

199 200 201 202 203 204

RI PT

198

Cheng S, Hu YH, Zhang M, Sun L. Analysis of the vaccine potential of a natural avirulent Edwardsiella tarda isolate. Vaccine 2010;28:2716-21.

Egusa S. Some bacterial diseases of freshwater fishes in Japan. Fish Pathol

SC

197

Microbiol 2015;23:126-32.

1976;10:103-14.

Iida T, Wakabayashi H. Resistance of Edwardsiella tarda to Opsonophagocytosis of Eel

M AN U

196

Neutrophils. Fish Pathol 1993;28:191-2.

Ishikawa E, Mori D, Yamasaki S. Recognition of Mycobacterial Lipids by Immune Receptors. Trends Immunol 2017;38:66-76.

Jiao XD, Cheng S, Hu YH, Sun L. Comparative study of the effects of aluminum

206

adjuvants and Freund's incomplete adjuvant on the immune response to an

207

Edwardsiella tarda major antigen. Vaccine 2010;28:1832-7.

EP

TE D

205

Kaneshige N, Jirapongpairoj W, Hirono I, Kondo H. Temperature-dependent regulation

209

of gene expression in Japanese flounder Paralichthys olivaceus kidney after

210 211

AC C

208

Edwardsiella

tarda

formalin-killed

cells.

Fish

Shellfish

Immunol.

2016;59:298-304.

212

Kondo H, Kawana Y, Suzuki Y, Hirono I. Comprehensive gene expression profiling in

213

Japanese flounder kidney after injection with two different formalin-killed

214

pathogenic bacteria. Fish Shellfish Immunol 2014;41:437-40.

215

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time

11

ACCEPTED MANUSCRIPT

quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8.

217

Matsumoto M, Araki K, Hayashi K, Takeuchi Y, Shiozaki K, Suetake H, Yamamoto A.

218

Adjuvant effect of recombinant interleukin-12 in the Nocardiosis formalin-killed

219

vaccine of the amberjack Seriola dumerili. Fish Shellfish Immunol 2017;67:263-9.

223 224 225 226 227

SC

222

Japanese flounder against Edwardsiellosis. Fish Pathol 1995;30:251-6.

Miyazaki T, Kaige N. Comparative histopathology of Edwardsiellosis in fishes. Fish Pathol 1985;20:219e27.

M AN U

221

Mekuchi T, Kiyokawa T, Honda K, Nakai T, Muroga K. Vaccination trails in the

Nakatsugawa T. Edwardsiella tarda isolated from cultured young flounders. Fish Pathol 1983;18:99-101.

Park SB, Aoki T, Jung TS. Pathogenesis of and strategies for preventing Edwardsiella tarda infection in fish. Vet Res. 2012;43:67.

TE D

220

RI PT

216

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers

229

differential expression analyses for RNA-sequencing and microarray studies.

230

Nucleic Acids Res. 2015;43:e47.

232 233 234 235 236 237

Srinivasa Rao PS, Lim TM, Leung KY. Opsonized virulent Edwardsiella tarda strains

AC C

231

EP

228

are able to adhere to and survive and replicate within fish phagocytes but fail to

stimulate reactive oxygen intermediates. Infect Immun 2001; 69:5689-97.

Sun Y, Liu CS, Sun L. Isolation and analysis of the vaccine potential of an attenuated Edwardsiella tarda strain. Vaccine. 2010;28:6344-50. Taechavasonyoo A, Hirono I, Kondo H. The immune-adjuvant effect of Japanese flounder Paralichthys olivaceus IL-1β. Dev Comp Immunol 2013;41:564-8.

12

ACCEPTED MANUSCRIPT

238

Tafalla C, Bøgwald J, Dalmo RA. Adjuvants and immunostimulants in fish vaccines: current

knowledge

240

2013;35:1740-50.

and

future

perspectives.

Fish

Shellfish

Immunol

RI PT

239

Takano T, Matsuyama T, Oseko N, Sakai T, Kamaishi T, Nakayasu C, Sano M, Iida T.

242

The efficacy of five avirulent Edwardsiella tarda strains in a live vaccine against

243

Edwardsiellosis in Japanese flounder, Paralichthys olivaceus. Fish Shellfish

244

Immunol. 2010;29:687-93.

SC

241

Tang X, Zhan W, Sheng X, Chi H. Immune response of Japanese flounder Paralichthys

246

olivaceus to outer membrane protein of Edwardsiella tarda. Fish Shellfish Immunol

247

2010;28:333-43.

Watford WT, Moriguchi M, Morinobu A, O'Shea JJ. The biology of IL-12: coordinating

249

innate

and

adaptive

250

2003;14:361-8.

immune

responses.

TE D

248

M AN U

245

Cytokine

Growth

Factor

Rev

Yasunaga N, Ogawa S, Hatai K. Characteristics of the fish pathogen Edwardsiella

252

isolated from several species of cultured marine fishes. Bull Nagasaki Pref Inst Fish

253

1982;8:57-65.

255 256

AC C

254

EP

251

Zundler S, Neurath MF. Interleukin-12: Functional activities and implications for disease. Cytokine Growth Factor Rev. 2015;26:559-68.

13

ACCEPTED MANUSCRIPT

Legends for figures

258

Figure 1 (A) Cumulative survival of vaccinated fish after the challenge with E. tarda.

259

(B) Antibody titers at 2 weeks after vaccination with FKC, FKC+FCA or FKC+FIA.

260

Serum samples were collected from 5 fish/group, diluted 1:20, and then analyzed by

261

ELISA. Each point represents an individual fish and black bar indicate the average of

262

each group. Different letters represent significant differences as determined by Tukey's

263

HSD (P < 0.05). (C, D) Expressions of IFNγ (C) and IL-12p35 (D) genes in the spleen

264

from 3 fish/group at 6 h and on 3 d after PBS, FKC, FKC+FCA and FKC+FIA injection.

265

Expression is expressed as Log2 values, relative to the average of the PBS group. Each

266

point represents an individual fish and black bar indicate the average of each group.

267

Asterisk indicates a significance difference by one-way ANOVA (P < 0.05).

SC

M AN U

TE D EP AC C

268

RI PT

257

14

ACCEPTED MANUSCRIPT

FKC 6h Product name

CUST_12226_PI426483990

AB427185.1

CUST_12932_PI426483990

a

CUST_351_PI426483993 CUST_48_PI426483993

b

CUST_49_PI426483993

b

a

Log2FC

P_value

CC chemokine-like

4.8

6.1E-06

AB427185.1

CC chemokine-like

6.4

3.3E-06

AB427185.1

CC chemokine-like

6.0

BAG50577.1

Interferon gamma

FKC 3d

FKC+FCA 3d

Log2FC

P value

Log2FC

P value

Log2FC

P value

4.7

7.6E-06

1.4

9.4E-02

1.6

9.9E-03

5.9

6.8E-06

2.4

1.8E-02

1.6

9.9E-03

6.2E-05

5.5

1.5E-04

1.8

1.8E-01

2.1

9.2E-03

6.4

3.9E-07

1.9

1.6E-02

2.1

8.8E-03

2.6

4.1E-02

5.9

3.1E-06

1.3

1.7E-01

1.3

1.9E-01

4.2

1.3E-03

5.6

4.3E-06

1.2

2.0E-01

1.2

1.9E-01

3.2

7.2E-03

5.8

3.7E-05

5.6

5.5E-05

2.7

2.3E-02

2.6

4.1E-02

7.4

5.9E-06

7.3

6.8E-06

3.9

2.2E-03

0.9

1.8E-01

4.1

4.9E-06

2.6

4.5E-04

0.6

3.3E-01

3.1

3.3E-04

SC

Acc. No. a

FKC+FCA 6h

M AN U

Probe ID

RI PT

Table List of cytokines up-regulated after the treatments

Interferon gamma

CUST_9251_PI426483990

BAG50577.1

Interferon gamma

CUST_7075_PI426483990

c

AB720983.1

Interleukin 1 beta

CUST_9569_PI426483990

c

AB720983.1

Interleukin 1 beta

DQ267937.1

Interleukin 6

BAF91496.1

M17 homologue

4.4

1.7E-06

5.3

2.7E-07

0.5

3.5E-01

2.2

1.6E-02

BAF91496.1

M17 homologue

4.6

7.4E-07

5.6

1.2E-07

0.9

1.8E-01

2.5

5.2E-03

CUST_290_PI426483993 CUST_10972_PI426483990 CUST_310_PI426483993

d

d

TE D

BAG50577.1 b

EP

Probes indicated by the same alphabet encode the same gene products. The values were compared with those before the treatments, and the Log2

AC C

transformed fold-change values (Log2FC) and P value were represented. both Log2FC > 3.0 and P value < 1.0E-05 were indicated by gray.

ACCEPTED MANUSCRIPT

(A)

(B)

100

FKC+FIA *

60 50 30 10 0 1

2

3

4

5

6

7

8

Days post challenge

(C)

9

10

a

FKC +FCA

FKC +FIA

b

1.0

c

c

M AN U

40

1.5

a

SC

70

Absorbance (405 nm)

FKC+FCA *

0.5

0.0

Before PBS injection

FKC

(D)

TE D

10

*

* p < 0.05

8 6

EP

4 2

AC C

0

PBS FKC

FKC FKC +FCA +FIA

6h

PBS FKC FKC FKC +FCA +FIA

3d

Relative IL-12p35 mRNA levels (Log 2)

Survival rate (%)

FKC

80

20

Relative IFNγ mRNA levels (Log 2)

2.0

PBS

90

-2

RI PT

Fig. 1

5

* p < 0.05 4

*

3 2 1 0

*

-1 -2 PBS FKC

FKC FKC +FCA +FIA

6h

PBS FKC FKC FKC +FCA +FIA

3d

ACCEPTED MANUSCRIPT Highlights •

Effects of adjuvants (FCA, FIA) on protection and immune response of Japanese flounder were evaluated. Freund’s adjuvants enhanced antibody responses but did not confer protection.



Freund’s adjuvants suppressed the induction of IFNγ and IL12p35 mRNA expression

RI PT



AC C

EP

TE D

M AN U

SC

after the FKC vaccination.